-
1
-
-
0000525588
-
FIGO stages: 1988 revision
-
1. Announcement. FIGO stages: 1988 revision. Gynecol Oncol 35:125-127, 1988
-
(1988)
Gynecol Oncol
, vol.35
, pp. 125-127
-
-
-
2
-
-
0023840831
-
Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups
-
2. Mittal KR, Schwartz PE, Barwick KW: Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups. Cancer 61:538-545, 1988
-
(1988)
Cancer
, vol.61
, pp. 538-545
-
-
Mittal, K.R.1
Schwartz, P.E.2
Barwick, K.W.3
-
3
-
-
0025991205
-
Evaluation of the reproducibility of the revised 1988 International Federation of Gynecology and Obstetrics grading system of endometrial cancers with special emphasis on nuclear grading
-
3. Nielsen AL, Thomsen HK, Nyholm HCJ: Evaluation of the reproducibility of the revised 1988 International Federation of Gynecology and Obstetrics grading system of endometrial cancers with special emphasis on nuclear grading. Cancer 68:2303-2309, 1991
-
(1991)
Cancer
, vol.68
, pp. 2303-2309
-
-
Nielsen, A.L.1
Thomsen, H.K.2
Nyholm, H.C.J.3
-
4
-
-
0027958383
-
The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma: A Gynecologic Oncology Group study
-
4. Zaino RJ, Silverber SG, Norris HJ, Bundy BN, Morrow CP, Okagaki T: The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma: A Gynecologic Oncology Group study. Int J Gynecol Pathol 13:29-36, 1994
-
(1994)
Int J Gynecol Pathol
, vol.13
, pp. 29-36
-
-
Zaino, R.J.1
Silverber, S.G.2
Norris, H.J.3
Bundy, B.N.4
Morrow, C.P.5
Okagaki, T.6
-
5
-
-
0023916071
-
Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone
-
5. Baak JPA, Nauta JJP, Brekelmans W, Bezemer PD: Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone. J Pathol 154:335-341, 1988
-
(1988)
J Pathol
, vol.154
, pp. 335-341
-
-
Baak, J.P.A.1
Nauta, J.J.P.2
Brekelmans, W.3
Bezemer, P.D.4
-
6
-
-
0024512150
-
A comparative morphometric and cytophotometric study of endometrial hyperplasia, atypical hyperplasia, and endometrial carcinoma
-
6. Norris HJ, Becker RL, Mikel UV: A comparative morphometric and cytophotometric study of endometrial hyperplasia, atypical hyperplasia, and endometrial carcinoma. Hum Pathol 20:219-223, 1989
-
(1989)
Hum Pathol
, vol.20
, pp. 219-223
-
-
Norris, H.J.1
Becker, R.L.2
Mikel, U.V.3
-
7
-
-
0028922608
-
Confirmation of the prognostic value of the ECPI-1 score (myometrial invasion, DNA-ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-up
-
7. Baak JPA, Snijders WP, Diest PJ, Horvath EA, Kenemans P: Confirmation of the prognostic value of the ECPI-1 score (myometrial invasion, DNA-ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-up. Int J Gynecol Cancer 5:112-116, 1995
-
(1995)
Int J Gynecol Cancer
, vol.5
, pp. 112-116
-
-
Baak, J.P.A.1
Snijders, W.P.2
Diest, P.J.3
Horvath, E.A.4
Kenemans, P.5
-
8
-
-
0020529788
-
Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease
-
8. Christopherson WM, Alberhasky RC, Connelly PJ: Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease. Cancer 51:1705-1709, 1983
-
(1983)
Cancer
, vol.51
, pp. 1705-1709
-
-
Christopherson, W.M.1
Alberhasky, R.C.2
Connelly, P.J.3
-
9
-
-
0001637183
-
Endometrial carcinoma
-
Kurman RJ (ed) New York, Springer-Verlag
-
9. Kurman RJ, Zaino RJ, Norris HJ: Endometrial Carcinoma, in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract New York, Springer-Verlag, 1994, pp 439-486
-
(1994)
Blaustein's Pathology of the Female Genital Tract
, pp. 439-486
-
-
Kurman, R.J.1
Zaino, R.J.2
Norris, H.J.3
-
10
-
-
0020034644
-
Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma
-
10. Kurman RJ, Norris HJ: Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49:2547-2559, 1982
-
(1982)
Cancer
, vol.49
, pp. 2547-2559
-
-
Kurman, R.J.1
Norris, H.J.2
-
11
-
-
0000808622
-
Corpus cancer staging
-
11. FIGO news. Corpus cancer staging, Int J Gynaecol Obstet 28:190, 1989
-
(1989)
Int J Gynaecol Obstet
, vol.28
, pp. 190
-
-
-
12
-
-
0022500280
-
Endometrial adenocarcinoma: A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors
-
12. Geisinger KR, Homesley HD, Morgan TM, Kute TE, Marshall RB: Endometrial adenocarcinoma: a multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors. Cancer 58:1518-1525, 1986
-
(1986)
Cancer
, vol.58
, pp. 1518-1525
-
-
Geisinger, K.R.1
Homesley, H.D.2
Morgan, T.M.3
Kute, T.E.4
Marshall, R.B.5
-
13
-
-
0030000416
-
Proliferating cell nuclear antigen (PCNA) immunoreactivity in stage I endometrial carcinomas: A new prognostic factor
-
13. Garzetti GG, Ciavattini A, Goteri G, Stramazzotti D, Fabris G, Mannello B, Romanini C: Proliferating cell nuclear antigen (PCNA) immunoreactivity in stage I endometrial carcinomas: a new prognostic factor. Int J Gynecol Cancer 6:186-192, 1996
-
(1996)
Int J Gynecol Cancer
, vol.6
, pp. 186-192
-
-
Garzetti, G.G.1
Ciavattini, A.2
Goteri, G.3
Stramazzotti, D.4
Fabris, G.5
Mannello, B.6
Romanini, C.7
-
14
-
-
0028243915
-
Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma
-
14. Sorbe B, Risberg N, Thornwaite J: Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma. Int J Gynecol Cancer 4:94-100, 1994
-
(1994)
Int J Gynecol Cancer
, vol.4
, pp. 94-100
-
-
Sorbe, B.1
Risberg, N.2
Thornwaite, J.3
-
15
-
-
0029919587
-
p53 Overexpression and bcl-2 persistence in endometrial carcinoma: Comparison of papillary serous and endometrioid subtypes
-
15. Zheng W, Cao P, Zheng M, Kramer EE, Godwin TA: p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. Gynecol Oncol 61:167-174, 1996
-
(1996)
Gynecol Oncol
, vol.61
, pp. 167-174
-
-
Zheng, W.1
Cao, P.2
Zheng, M.3
Kramer, E.E.4
Godwin, T.A.5
-
16
-
-
0026780539
-
Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion
-
16. Ambros RA, Kurman RJ: Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecol Oncol 45:235-239, 1992
-
(1992)
Gynecol Oncol
, vol.45
, pp. 235-239
-
-
Ambros, R.A.1
Kurman, R.J.2
-
17
-
-
0026450937
-
Delay in fixation does not affect the immunoreactivity of proliferating cell nuclear antigen (PCNA)
-
17. Start RD, Cross SS, Clelland C, Silcocks PB, Rogers K, Smith JH: Delay in fixation does not affect the immunoreactivity of proliferating cell nuclear antigen (PCNA). J Pathol 168:197-199, 1992
-
(1992)
J Pathol
, vol.168
, pp. 197-199
-
-
Start, R.D.1
Cross, S.S.2
Clelland, C.3
Silcocks, P.B.4
Rogers, K.5
Smith, J.H.6
|